Position in KRYS
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$385,793
+$118,691 QoQ
Shares Held
1,038
+0.4% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#264
of 419 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 71%
Shared 0%
None 29%
Common Shares in KRYS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026HOHIMER WEALTH MANAGEMENT, LLC holds $8,657,709 across 7 Biotechnology names. KRYS ranks #4 (4.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SMMT |
Summit Therapeutics Inc.
|
339,100 | $4,940,687 | |
| 2 | ACAD |
Acadia Pharmaceuticals Inc
|
91,800 | $2,322,540 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,530 | $759,996 | |
| 4 | KRYS |
Krystal Biotech, Inc.
This page
|
1,038 | $385,793 | |
| 5 | INVA |
Innoviva, Inc.
|
9,505 | $215,858 | |
| 6 | ATYR |
aTYR PHARMA INC
|
55,000 | $32,835 | |
| 7 | 11,033 | $0 |
All Filings in KRYS
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $385,793 | 1,038 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $267,102 | 1,034 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $299,299 | 1,214 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $214,483 | 1,215 | Shares | Sole | 2025-11-12 | |
| No filing history on record for this holder in this stock. | ||||||